OXFORD BIOMEDICA LTD has a total of 593 patent applications. It increased the IP activity by 175.0%. Its first patent ever was published in 1990. It filed its patents most often in United Kingdom, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are FATE THERAPEUTICS INC, PETTE HEINRICH INST and CANJI.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 165 | |
#2 | EPO (European Patent Office) | 99 | |
#3 | United States | 78 | |
#4 | Australia | 59 | |
#5 | WIPO (World Intellectual Property Organization) | 59 | |
#6 | China | 38 | |
#7 | Canada | 34 | |
#8 | Japan | 12 | |
#9 | Israel | 10 | |
#10 | New Zealand | 10 | |
#11 | Norway | 8 | |
#12 | Republic of Korea | 6 | |
#13 | South Africa | 6 | |
#14 | Hong Kong | 3 | |
#15 | Bulgaria | 2 | |
#16 | Czechia | 2 | |
#17 | Poland | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks | |
#5 | Agriculture | |
#6 | Micro-structure and nano-technology | |
#7 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Analysing materials | |
#6 | Measuring microorganism processes | |
#7 | Enzymes | |
#8 | Animal care | |
#9 | Nanostructure applications | |
#10 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Kingsman Alan John | 132 |
#2 | Kingsman Susan Mary | 125 |
#3 | Mitrophanous Kyriacos | 101 |
#4 | Carroll Miles William | 47 |
#5 | Kim Narry | 44 |
#6 | Kingsman Susan | 40 |
#7 | Myers Kevin Alan | 37 |
#8 | Ellard Fiona Margaret | 31 |
#9 | Rohll Jonathan | 31 |
#10 | Harrop Richard | 31 |
Publication | Filing date | Title |
---|---|---|
GB202017820D0 | Production of lentiviral vectors | |
GB202017725D0 | Method | |
WO2021014157A1 | Enhancing production of lentiviral vectors | |
GB202003711D0 | Lentiviral vectors | |
GB202003709D0 | Lentiviral vectors | |
GB202003710D0 | Lentiviral vectors | |
GB202003412D0 | Replication competent virus assay | |
GB202001997D0 | Enhancing production of lentiviral vectors | |
GB202001996D0 | Production of lentiviral vectors | |
GB202001998D0 | Production system | |
GB201916452D0 | Production system | |
GB201910518D0 | Enhancing production of lentiviral vectors | |
GB201817226D0 | Angiostatin and anti-vegf compositions and methods | |
GB201814590D0 | Viral vector production system | |
KR20190129861A | Way | |
JP2018117622A | Construct | |
EP3633040A1 | Retroviral vector | |
GB201721603D0 | Method | |
US2017073702A1 | Virus purification | |
CN106029898A | Viral vector production system |